GNI Group Ltd. (2160.T)
JPY 1828.0
(0.66%)
JPY 1828.0
(0.66%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2 Billion JPY | 1167.88% |
| 2022 | 157.74 Million JPY | -43.81% |
| 2021 | 280.72 Million JPY | 23.52% |
| 2020 | 227.26 Million JPY | -80.35% |
| 2019 | 1.15 Billion JPY | -24.4% |
| 2018 | 1.53 Billion JPY | 219.19% |
| 2017 | 479.41 Million JPY | -1.81% |
| 2016 | 488.27 Million JPY | 4.1% |
| 2015 | 469.04 Million JPY | 15.16% |
| 2014 | 407.31 Million JPY | 30.59% |
| 2013 | 311.9 Million JPY | 19.49% |
| 2012 | 261.02 Million JPY | 5.02% |
| 2011 | 248.54 Million JPY | 0.0% |
| 2010 | - JPY | 0.0% |
| 2008 | 16.4 Million JPY | -60.46% |
| 2007 | 41.48 Million JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.5 Billion JPY | -6.25% |
| 2024 Q2 | 1.4 Billion JPY | -6.67% |
| 2023 Q1 | 118.98 Million JPY | -24.57% |
| 2023 Q4 | 2 Billion JPY | 2286.41% |
| 2023 Q3 | 83.8 Million JPY | -22.02% |
| 2023 Q2 | 107.47 Million JPY | -9.67% |
| 2023 FY | 2 Billion JPY | 1167.88% |
| 2022 Q3 | 226.09 Million JPY | -10.05% |
| 2022 Q4 | 157.74 Million JPY | -30.23% |
| 2022 FY | 157.74 Million JPY | -43.81% |
| 2022 Q1 | 263.07 Million JPY | -6.29% |
| 2022 Q2 | 251.34 Million JPY | -4.46% |
| 2021 Q1 | 149.53 Million JPY | -34.2% |
| 2021 Q3 | 193.56 Million JPY | -1.83% |
| 2021 Q4 | 280.72 Million JPY | 45.03% |
| 2021 FY | 280.72 Million JPY | 23.52% |
| 2021 Q2 | 197.17 Million JPY | 31.85% |
| 2020 Q3 | 967.26 Million JPY | -4.05% |
| 2020 Q2 | 1 Billion JPY | -4.01% |
| 2020 FY | 227.26 Million JPY | -80.35% |
| 2020 Q4 | 227.26 Million JPY | -76.5% |
| 2020 Q1 | 1.05 Billion JPY | -9.21% |
| 2019 Q1 | 1.39 Billion JPY | -9.0% |
| 2019 FY | 1.15 Billion JPY | -24.4% |
| 2019 Q4 | 1.15 Billion JPY | -7.67% |
| 2019 Q3 | 1.25 Billion JPY | -17.24% |
| 2019 Q2 | 1.51 Billion JPY | 8.71% |
| 2018 Q4 | 1.53 Billion JPY | 135.33% |
| 2018 Q2 | 658.35 Million JPY | -1.86% |
| 2018 FY | 1.53 Billion JPY | 219.19% |
| 2018 Q3 | 650.24 Million JPY | -1.23% |
| 2018 Q1 | 670.8 Million JPY | 39.92% |
| 2017 Q1 | 212.32 Million JPY | -56.52% |
| 2017 Q4 | 479.41 Million JPY | -8.26% |
| 2017 FY | 479.41 Million JPY | -1.81% |
| 2017 Q3 | 522.59 Million JPY | 87.15% |
| 2017 Q2 | 279.23 Million JPY | 31.51% |
| 2016 Q2 | 452.06 Million JPY | -11.37% |
| 2016 Q4 | 488.27 Million JPY | 10.33% |
| 2016 Q3 | 442.55 Million JPY | -2.1% |
| 2016 FY | 488.27 Million JPY | 4.1% |
| 2016 Q1 | 510.06 Million JPY | 8.75% |
| 2015 FY | 469.04 Million JPY | 15.16% |
| 2015 Q3 | 619.92 Million JPY | -4.15% |
| 2015 Q2 | 646.77 Million JPY | 1.66% |
| 2015 Q1 | 636.24 Million JPY | 56.21% |
| 2015 Q4 | 469.04 Million JPY | -24.34% |
| 2014 FY | 407.31 Million JPY | 30.59% |
| 2014 Q2 | 285.71 Million JPY | -3.72% |
| 2014 Q4 | 407.31 Million JPY | -21.81% |
| 2014 Q3 | 520.91 Million JPY | 82.32% |
| 2014 Q1 | 296.74 Million JPY | -4.86% |
| 2013 Q2 | 290.28 Million JPY | 2.41% |
| 2013 Q3 | 287.07 Million JPY | -1.1% |
| 2013 FY | 311.9 Million JPY | 19.49% |
| 2013 Q4 | 311.9 Million JPY | 8.65% |
| 2013 Q1 | 283.44 Million JPY | 8.59% |
| 2012 FY | 261.02 Million JPY | 5.02% |
| 2012 Q1 | 244.13 Million JPY | -1.78% |
| 2012 Q2 | 231.22 Million JPY | -5.29% |
| 2012 Q3 | 225 Million JPY | -2.69% |
| 2012 Q4 | 261.02 Million JPY | 16.01% |
| 2011 Q2 | - JPY | 0.0% |
| 2011 Q4 | 248.54 Million JPY | 10.03% |
| 2011 FY | 248.54 Million JPY | 0.0% |
| 2011 Q3 | 225.88 Million JPY | 0.0% |
| 2011 Q1 | - JPY | 0.0% |
| 2010 Q1 | - JPY | 0.0% |
| 2010 FY | - JPY | 0.0% |
| 2010 Q3 | - JPY | 0.0% |
| 2010 Q2 | - JPY | 0.0% |
| 2010 Q4 | - JPY | 0.0% |
| 2009 Q3 | 3.86 Million JPY | -61.9% |
| 2009 Q2 | 10.13 Million JPY | -38.23% |
| 2009 Q1 | 16.4 Million JPY | -27.66% |
| 2008 FY | 16.4 Million JPY | -60.46% |
| 2008 Q4 | 22.67 Million JPY | 0.0% |
| 2007 FY | 41.48 Million JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | -160.745% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| Linical Co., Ltd. | 1.49 Billion JPY | -33.338% |
| Trans Genic Inc. | 1.32 Billion JPY | -50.707% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -255981.946% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 14.788% |
| AnGes, Inc. | 214.94 Million JPY | -830.453% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -1771.8% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 96.836% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -2265.157% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -80.356% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -6941.758% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | -128.415% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -5021.639% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | -8.816% |
| PeptiDream Inc. | 19.63 Billion JPY | 89.814% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | -1141.465% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | -403.778% |
| Healios K.K. | 450 Million JPY | -344.444% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -2487.623% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | -158.635% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | -153.807% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | -307.041% |
| StemCell Institute Inc. | 6.67 Million JPY | -29858.059% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | -1291.304% |